CAPTRUST Financial Advisors
AKYA

CAPTRUST Financial Advisors’s Akoya BioSciences AKYA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-90
Closed -$1K – 4903
2021
Q4 		$1K Buy
+90
New +$1.18K ﹤0.01% 4525

Other funds holding AKYA

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

CAPTRUST Financial Advisors's AKYA Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of Akoya BioSciences (AKYA) in Q1 2022, closing a stake of 90 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in AKYA in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 46 funds tracked by Wall St. Rank hold AKYA as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining Akoya BioSciences position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 90 Akoya BioSciences shares in Q1 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Akoya BioSciences in Q4 2021 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Akoya BioSciences position peaked at $1K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.